Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning, ESCAPE Study

NCT02308332 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT02308332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02308332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning, ESCAPE Study
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2015
Completion date
June 30, 2017
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv associated neurocognitive disorder, neurocognitive decline